Ameriprise Financial Inc Intercept Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $368,331 - $689,837	-36,870 Reduced 74.83%	12,399 $229,000
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $55,524 - $116,800	6,055 Added 14.01%	49,269 $544,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $18,970 - $32,868	1,514 Added 3.63%	43,214 $580,000
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $551,393 - $765,112	-47,493 Reduced 53.25%	41,700 $515,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $72,258 - $116,584	-5,918 Reduced 6.22%	89,193 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $89,727 - $156,524	7,990 Added 9.17%	95,111 $1.31 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $126,052 - $167,724	9,428 Added 12.13%	87,121 $1.42 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $816,359 - $1.12 Million	57,168 Added 278.53%	77,693 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $306,473 - $482,948	-23,593 Reduced 53.48%	20,525 $305,000
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $320,161 - $507,370	20,709 Added 88.47%	44,118 $881,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $22.9 Million - $44.8 Million	-1,187,123 Reduced 98.07%	23,409 $540,000
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $8.55 Million - $14.8 Million	349,254 Added 40.55%	1,210,532 $29.9 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $27.1 Million - $37.1 Million	694,080 Added 415.12%	861,278 $35.7 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $10.7 Million - $21.2 Million	-229,836 Reduced 57.89%	167,198 $8.01 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $6.28 Million - $15.4 Million	129,804 Added 48.57%	397,034 $25 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $4.12 Million - $8.91 Million	71,818 Added 36.75%	267,230 $33.1 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $4.02 Million - $5.51 Million	68,428 Added 53.89%	195,412 $13 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $7.18 Million - $11.1 Million	92,313 Added 266.25%	126,984 $10.1 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $14,692 - $19,308	160 Added 0.46%	34,671 $3.87 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $1.54 Million - $2.28 Million	-18,003 Reduced 34.28%	34,511 $3.48 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $894,899 - $1.29 Million	10,113 Added 23.85%	52,514 $6.64 Million
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $2.82 Million - $4.02 Million	-46,947 Reduced 52.54%	42,401 $3.56 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $3.29 Million - $4.2 Million	-62,434 Reduced 41.13%	89,348 $5.5 Million
Q4 2017 Feb 12, 2018	SELL	$58.2 - $72.76 $75.6 Million - $94.5 Million	-1,298,730 Reduced 89.54%	151,782 $8.87 Million
Q3 2017 Nov 07, 2017	BUY	$57.01 - $118.75 $82.7 Million - $172 Million	1,450,512	1,450,512 $84.2 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account